“Macrovascular and microvascular complications in type 2 diabetic Iraqi patients treated by metformin and glibenclamide versus metformin and sitagliptin”, INJNS, vol. 25, no. 1, pp. 56–63, Jun. 2012, doi: 10.58897/injns.v25i1.118.